Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Pediatric Blood & Cancer|July 27, 2010
Outcome for children treated for relapsed or refractory acute myelogenous leukemia (rAML): a Therapeutic Advances in Childhood Leukemia (TACL) Consortium studyMatthew F Gorman, Lingyun Ji, Richard H Ko, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 12, 2015
Feasibility Study of a Novel Experimental Induction Protocol Combining B43-PAP (Anti-CD19) Immunotoxin With Standard Induction Chemotherapy in Children and Adolescents With Relapsed B-Lineage ALL: A Report From the Children's Oncology GroupHolly J Meany, Nita L Seibel, Mark Krailo, et al.Pediatric Blood & Cancer|September 1, 2016
Review at a multidisciplinary tumor board impacts critical management decisions of pediatric patients with cancerArun Thenappan, Ihab Halaweish, Rajen J Mody, et al.Blood|May 12, 2005
Safety and efficacy of gemtuzumab ozogamicin in pediatric patients with advanced CD33+ acute myeloid leukemiaRobert J Arceci, Jane Sande, Beverly Lange, et al.Journal of Cancer Survivorship : Research and Practice|June 27, 2018
Insurance, chronic health conditions, and utilization of primary and specialty outpatient services: a Childhood Cancer Survivor Study reportEmily L Mueller, Elyse R Park, Anne C Kirchhoff, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 30, 2005
Pilot trial on the use of etanercept and methylprednisolone as primary treatment for acute graft-versus-host diseaseJoseph P Uberti, Lois Ayash, Voravit Ratanatharathorn, et al.Blood|April 13, 2006
Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children's Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic leukemia, reported by the Children's Oncology GroupYousif Matloub, Susan Lindemulder, Paul S Gaynon, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 3, 2015
131I-metaiodobenzylguanidine with intensive chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma. A new approaches to neuroblastoma therapy (NANT) phase II studyGregory A Yanik, Judith G Villablanca, John M Maris, et al.Pediatric Blood & Cancer|August 22, 2022
Nelarabine, etoposide, and cyclophosphamide in relapsed pediatric T-acute lymphoblastic leukemia and T-lymphoblastic lymphoma (study T2008-002 NECTAR)James A Whitlock, Jemily Malvar, Luciano Dalla-Pozza, et al.Leukemia|May 6, 2018
Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia & lymphoma studyWeili Sun, Jemily Malvar, Richard Sposto, et al.Pageof 4